LIN Yuanchao, LIU Yiping. Effect of retroauricular injection of dexamethasone combined with intravenous drip of ginkgo biloba extract injection in treating sudden deafness[J]. Journal of Clinical Medicine in Practice, 2023, 27(8): 109-112. DOI: 10.7619/jcmp.20223850
Citation: LIN Yuanchao, LIU Yiping. Effect of retroauricular injection of dexamethasone combined with intravenous drip of ginkgo biloba extract injection in treating sudden deafness[J]. Journal of Clinical Medicine in Practice, 2023, 27(8): 109-112. DOI: 10.7619/jcmp.20223850

Effect of retroauricular injection of dexamethasone combined with intravenous drip of ginkgo biloba extract injection in treating sudden deafness

More Information
  • Received Date: December 26, 2022
  • Revised Date: March 03, 2023
  • Available Online: May 10, 2023
  • Objective 

    To observe the clinical effect of retroauricular injection of dexamethasone combined with intravenous drip of ginkgo biloba extract injection in treatment of patients with sudden deafness.

    Methods 

    The clinical materials of 108 patients with sudden deafness in our hospital from January 2019 to December 2021 were retrospectively analyzed, and 54 cases treated with retroauricular injection of dexamethasone were enrolled in control group, while 54 cases treated with additional intravenous drip of ginkgo biloba extract injection on the basis of the control group were enrolled in observation group. After 2 weeks of treatment, the clinical efficacy, hearing recovery, hemodynamic indicators, coagulation function indicators and adverse reactions were compared between the two groups.

    Results 

    Before treatment, the hearing levels of patients in the observation group and the control group were (43.88±9.36) and (42.14±8.34) dB respectively, and there was no significant difference between two groups (P > 0.05); after treatment, the hearing level of patients in the observation group was (13.41±2.29) dB, and was (18.17±2.34) dB in the control group; after treatment, the hearing levels in both groups were significantly better those than before treatment, and the hearing level in the observation group was significantly better than that in the control group (P < 0.05). After treatment, the total effective rate of the observation group was 90.74%, which was significantly higher than 74.07% of the control group (P < 0.05). After treatment, the whole blood viscosity, plasma viscosity and hematocrit in both groups decreased significantly, and all the indicators in the observation group were significantly lower than those in the control group (P < 0.05). After treatment, the thrombin time, prothrombin time and activated partial thromboplastin time in both groups increased significantly, the level of platelet factor decreased significantly, and the improvement degrees of the above indicators in the observation group were significantly better than those in the control group (P < 0.05). Patients in both groups had no adverse reactions during treatment.

    Conclusion 

    For patients with sudden deafness, retroauricular injection of dexamethasone combined with intravenous drip of ginkgo biloba extract injection can improve the hemodynamic indicators and coagulation function, effectively alleviate the microcirculatory disorders in the inner ear, and promote the recovery of hearing.

  • [1]
    PRINCE A D P, STUCKEN E Z. Sudden sensorineural hearing loss: a diagnostic and therapeutic emergency[J]. J Am Board Fam Med, 2021, 34(1): 216-223. doi: 10.3122/jabfm.2021.01.200199
    [2]
    MICHELS T C, DUFFY M T, ROGERS D J. Hearing loss in adults: differential diagnosis and treatment[J]. Am Fam Physician, 2019, 100(2): 98-108.
    [3]
    王海茹, 王海涛, 郝玲. 耳后与全身应用糖皮质激素治疗突发性耳聋系统评价与meta分析[J]. 中华耳科学杂志, 2018, 16(5): 669-675. doi: 10.3969/j.issn.1672-2922.2018.05.015
    [4]
    林颖, 韦富贵. 耳后注射甲泼尼龙琥珀酸钠治疗突发性耳聋的效果及其对血浆Hcy水平的影响[J]. 重庆医学, 2021, 50(2): 211-214. https://www.cnki.com.cn/Article/CJFDTOTAL-CQYX202102007.htm
    [5]
    黄巧, 尹时华, 翟思佳, 等. 基于网络药理学探究银杏叶提取物治疗突发性耳聋的机制[J]. 中成药, 2020, 42(5): 1344-1351.
    [6]
    艾有琴, 周宁霞, 陈金湘. 耳后、鼓室注射地塞米松治疗伴2型糖尿病突聋患者的疗效分析[J]. 听力学及言语疾病杂志, 2020, 28(4): 448-449. https://www.cnki.com.cn/Article/CJFDTOTAL-TLXJ202004023.htm
    [7]
    中华耳鼻咽喉头颈外科杂志编辑委员会, 中华医学会耳鼻咽喉头颈外科学分会. 突发性聋诊断和治疗指南(2015)[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(6): 443-447. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHEB200608004.htm
    [8]
    胡潇红, 宁荣霞. 突发性耳聋的发病机制与治疗康复现状[J]. 中国康复, 2020, 35(9): 496-500. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLKF202009015.htm
    [9]
    LIU Y, CHEN Q Q, XU Y P. Research progress in refractory sudden hearing loss: steroid therapy[J]. J Int Med Res, 2020, 48(1): 300060519889426.
    [10]
    余茜, 李端超, 钟时勋. 糖皮质激素在治疗突发性耳聋中的应用[J]. 中华耳科学杂志, 2020, 18(2): 394-398.
    [11]
    YU G H, CHOI Y J, JUNG H J, et al. A comparison of single-dose and multiple divided daily-dose oral steroids for sudden sensorineural hearing loss[J]. Braz J Otorhinolaryngol, 2019, 85(6): 733-738.
    [12]
    罗平, 张渊, 贺丹, 等. 经咽鼓管途径鼓室内灌注给药治疗突发性耳聋的效果观察[J]. 实用医院临床杂志, 2022, 19(5): 167-170.
    [13]
    陈永禄, 温丽慧, 刘海媚, 等. 神经节苷脂钠联合高压氧治疗突发性耳聋患者的效果评估[J]. 现代生物医学进展, 2020, 20(16): 3181-3184, 3090.
    [14]
    李明飞, 王成章. 银杏叶提取物制备、检测及应用研究进展[J]. 现代化工, 2020, 40(1): 29-32.
    [15]
    SI X, YU Z Y, REN X L, et al. Efficacy and safety of standardized Ginkgo biloba L. leaves extract as an adjuvant therapy for sudden sensorineural hearing loss: a systematic review and meta-analysis[J]. J Ethnopharmacol, 2022, 282: 114587.
    [16]
    李萍. 耳后骨膜下注射甲基强的松龙琥珀酸钠与静脉滴注地塞米松治疗突发性耳聋的疗效对比[J]. 实用临床医药杂志, 2020, 24(6): 72-75, 82. doi: 10.7619/jcmp.202006020
    [17]
    张学红, 梁小微, 王鸿梅, 等. 巴曲酶联合银杏叶注射液治疗突发性耳聋的疗效及对患者凝血功能的影响[J]. 河北医学, 2018, 24(6): 979-983.
    [18]
    赵艳, 赖世佳, 艾如涛, 等. 金纳多联合巴曲酶对SHL患者氧化应激、血流动力学及凝血功能的影响[J]. 海南医学院学报, 2017, 23(21): 3028-3031.
    [19]
    CHEN T R, WEI L H, GUAN X Q, et al. Biflavones from Ginkgo biloba as inhibitors of human thrombin[J]. Bioorg Chem, 2019, 92: 103199.

Catalog

    Article views (226) PDF downloads (23) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return